Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Deflexifol by FivePhusion for Ependymoma: Likelihood of Approval
Deflexifol is under clinical development by FivePhusion and currently in Phase II for Ependymoma. According to GlobalData, Phase II drugs...